January 8th, 2016
Johnson & Johnson and USAID Expand Memorandum of Understanding to Address the Global Health Threat of Antibiotic-Resistant Bacteria
Antimicrobial resistance, and specifically multi-drug resistant tuberculosis (MDR-TB), is one of the world’s most serious public health threats. Although there has been a decline in TB incidence and mortality overall in the past 15 years, MDR-TB threatens to erode these gains. Globally, an estimated 480,000 people develop and 190,000 people die from MDR-TB every year.1
The good news is that many government, not-for-profit and private sector organizations are recognizing the need to thwart this spread of MDR-TB and are implementing local and global strategies to intensify the fight against TB. One of these is the U.S Government’s recent National Action Plan for combatting MDR-TB, a bold and important step forward by the White House.
I had the pleasure of speaking at the launch of this Plan in the White House in January. It was great to see so many public and private stakeholders discuss and challenge each other on what is required to meet the global targets set out by both the White House and the World Health Organization (HWHO) End-TB Strategy – to reduce TB deaths by 95% by 2035, and cut new cases by 90%.